China's new coronavirus hospital taking first patients

Hospital was built in 10 days


The first patients are being treated at a 1,000-bed hospital that was built in 10 days in China to deal with the coronavirus, according to an article on The Washington Times website.

Huoshenshan Hospital in Wuhan and a second 1,500-bed facility due to open this week were built by construction crews working around the clock.

The Wuhan healthcare facilities mark the second time China has built specialized hospitals in a matter of days. 

As severe acute respiratory syndrome (SARS) spread in 2003, a facility in Beijing was constructed in a week.

Read the article.



February 7, 2020


Topic Area: Infection Control


Recent Posts

Healthcare Workers Need Better Workplaces

New global survey finds frontline healthcare workers struggle with significant gaps in workplace satisfaction.


Protecting Patients Through Design and Compliance at Altru Health System

Case study: Altru Health System’s new “Hospital in the Park” pairs patient-focused design with durable, code-compliant exit solutions built for safety, performance and long-term flexibility.


Novant Health's $1B Expansion Plans Approved

The approval supports the master facility plan for Novant Health New Hanover Regional Medical Center.


What Lies Ahead for Healthcare Facilities Managers

Staffing shortages, rising regulatory scrutiny and accelerating adoption of AI are converging to reshape the way healthcare facilities are managed.


What's in the Future for Healthcare Restrooms?

Workforce shortages, rising hygiene expectations and connected technologies are pushing healthcare restrooms beyond basic utility.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.